Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern

The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.
By BY KATHERINE J. WU from NYT Health https://ift.tt/2FpxC9d
via IFTTT
Clinical Trials, Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), your-feed-healthcare
Source New York Times
Làm đẹp Blog 247